Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Top Cited Papers
- 7 December 2010
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 377 (9759), 31-41
- https://doi.org/10.1016/s0140-6736(10)62110-1
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Aspirin for the primary prevention of vascular events?Public Health, 2009
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementThe Lancet Oncology, 2009
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Aspirin, salicylates, and cancerThe Lancet, 2009
- Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: An example from the Mayo Lung ProjectLung Cancer, 2008
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2New England Journal of Medicine, 2007
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- Low-Dose Aspirin in the Primary Prevention of CancerJAMA, 2005